85

Extrawell Pharmaceutical Holdings LtdHKG 858 Stock Report

Last reporting period 30 Sep, 2023

Updated 19 Sep, 2024

Last price

Market cap $B

0.058

Micro

Exchange

XHKG - Hong Kong Exchange

858.HK Stock Analysis

85

Uncovered

Extrawell Pharmaceutical Holdings Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-12/100

Low score

Market cap $B

0.058

Dividend yield

Shares outstanding

2 390 B

Extrawell Pharmaceutical Holdings Ltd. engages in the marketing and distribution of pharmaceutical products. The company employs 172 full-time employees The firm operates its business through three segments. The Manufacturing segment is engaged in the development, manufacture and sales of pharmaceutical products. Its self-produced products include Transfer Factor Oral Solution, Wisk, ZhouBang and others. The Trading segment is engaged in the promotion and distribution of imported pharmaceuticals. Its imported products include Millibar and Skin Cap. The Gene Development segment is engaged in the commercial development and research, development of gene-related technologies.

View Section: Eyestock Rating